Kirkland Advises Carlyle-Backed ADICON on Acquisition of Crown Bioscience

Kirkland & Ellis is advising Carlyle-backed ADICON Holdings Limited (HKEX: 9860), a company engaged in the provision of independent clinical laboratory services, on its proposed acquisition of Crown Bioscience from JSR Life Sciences for an enterprise value of US$204 million. Crown Bioscience is a global contract research organization (CRO) dedicated to advancing precision medicine across oncology, immuno-oncology and other therapeutic areas. The transaction was announced on November 13, 2025.

Read the transaction announcement

The Kirkland team included corporate lawyers Joey Chau, Brian Ho, Ryan Choi and Gary Chan.